FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.400
-0.035 (-8.00%)
At close: Mar 9, 2026, 4:00 PM EDT
0.425
+0.025 (6.30%)
After-hours: Mar 9, 2026, 7:59 PM EDT

FibroBiologics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Net Income
-18.65-11.16-16.49-5.12-1.58
Upgrade
Depreciation & Amortization
0.830.570.440.09-
Upgrade
Other Amortization
0.63-0.080.39-
Upgrade
Stock-Based Compensation
2.692.221.770.27-
Upgrade
Other Operating Activities
1.42-4.097.31--
Upgrade
Change in Accounts Payable
-1.51.250.670.530.23
Upgrade
Change in Other Net Operating Assets
-1.81-0.69-0.18-0.22-0.06
Upgrade
Operating Cash Flow
-16.39-11.9-6.4-4.07-1.41
Upgrade
Capital Expenditures
-0.26-0.18-0.5--
Upgrade
Investing Cash Flow
-0.26-0.18-0.5--
Upgrade
Short-Term Debt Issued
4.389.97-4.32.28
Upgrade
Total Debt Issued
4.389.97-4.32.28
Upgrade
Short-Term Debt Repaid
-3.4-0.57--0.23-0.75
Upgrade
Total Debt Repaid
-3.4-0.57--0.23-0.75
Upgrade
Net Debt Issued (Repaid)
0.989.4-4.081.53
Upgrade
Issuance of Common Stock
6.597.51--0.29
Upgrade
Other Financing Activities
---2.35-0.3-
Upgrade
Financing Cash Flow
7.5716.9113.795.931.82
Upgrade
Net Cash Flow
-9.094.826.91.860.41
Upgrade
Free Cash Flow
-16.66-12.09-6.9-4.07-1.41
Upgrade
Free Cash Flow Per Share
-0.37-0.37-0.24-0.14-0.16
Upgrade
Cash Interest Paid
0.20.020--
Upgrade
Levered Free Cash Flow
-9.97-11.853.97-1.69-
Upgrade
Unlevered Free Cash Flow
-10.47-11.833.98-1.67-
Upgrade
Change in Working Capital
-3.310.560.490.310.17
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.